All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Abstract

Study on the Mechanism of Beta-Sitosterol Involved in the Regulation of Senile Postmenopausal Osteoporosis through PI3K-Akt Signal Pathway

Author(s): Yabo Liu and Yan Xue*
Department of Orthopedics, Second Ward, 1Department of Obstetrics and Gynecology, First Ward, Yan'an People's Hospital, Yan???an, Shaanxi Province 716000, China

Correspondence Address:
Yan Xue, 1Department of Obstetrics and Gynecology, First Ward, Yan'an People's Hospital, Yan???an, Shaanxi Province 716000, China, E-mail: 280608215@qq.com


To explore beta-sitosterol involved in regulating the mechanism of postmenopausal osteoporosis in the elderly through the phosphoinositide-3-kinase–protein kinase B. 90 Sprague Dawley grade female rats were selected as the research subjects and randomly divided into a control, beta-sitosterol treatment, and the model group. Establishing an elderly postmenopausal osteoporosis model using oophorectomy, beta-sitosterol treatment group was given 20 μmol/l, the model group and control group were given equal volume of 0.9 % physiological saline by gavage of sitosterol drugs. In terms of bone mineral density, the bone mineral density in the beta-sitosterol group was raised than that in the model group. The results of hematoxylin and eosin staining showed that the degree of osteoporosis in the beta-sitosterol group was less than that in the model group. Enzyme-linked immunosorbent assay results showed that the concentrations of serum estradiol, bone alkaline phosphatase, osteocalcin and procollagen N-terminal propeptide in the beta-sitosterol group were raised than those in the model group. Quantitative polymerase chain reaction results showed that the expression of phosphoinositide- 3-kinase–protein kinase B messenger ribonucleic acid in bone tissue of beta-sitosterol treated group was raised than that of model group. Western blot analysis showed that the expression of phosphoinositide-3- kinase–protein kinase B was increased in beta-sitosterol treated group. Further experiments confirmed that the protective effect of beta-sitosterol on senile postmenopausal osteoporosis could be reversed by inhibiting phosphoinositide-3-kinase–protein kinase B. Beta-sitosterol can regulate senile postmenopausal osteoporosis and regulate the expression of bone mineral density and osteogenesis-related factors through phosphoinositide- 3-kinase–protein kinase B signal pathway.

Full-Text | PDF

 
 
Google scholar citation report
Citations : 61564

Indian Journal of Pharmaceutical Sciences received 61564 citations as per google scholar report